Sleep and Neurodegenerative Diseases

ABSTRACT

Sleep disturbances are common in neurodegenerative diseases. Disturbed sleep can result in fatigue, irritability, morning headaches, impaired motor and cognitive skills, depression, and daytime somnolence. The major sleep complaints include insomnia, hypersomnia, parasomnia, excessive nocturnal motor activity, circadian sleep–wake rhythm disturbance, and respiratory dysrhythmia. The pathogenetic mechanisms of sleep disturbances may be secondary to direct structural alteration of the sleep–wake generating neurons or from several other indirect mechanisms. At the biochemical level, neurodegenerative diseases may be largely classified as tauopathies, α-synucleinopathies, and other diseases. Overnight polysomnography (PSG), Multiple Sleep Latency Test, Maintenance of Wakefulness Test, and actigraphy are some important diagnostic laboratory tests in the evaluation of sleep disturbances. Management of sleep disturbances is complex and is based primarily on the nature of the sleep disturbance. The clinical profiles, pathogenetic mechanisms, PSG findings, and management issues are discussed here with reference to some common neurodegenerative diseases.

KEYWORDS

Neurodegenerative disease - sleep disturbance - polysomnography (PSG) - molecular neurobiology

REFERENCES

• 1 Degenerative diseases of the nervous system. In: Ropper AH, Brown RH Adams and Victor's Principles of Neurology 8th ed. New York; McGraw Hill 2006: 1108
• 2 The Huntington's Disease Collaborative Research Group . A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.  Cell. 1993;  72(6) 971-983
• 3 Polymeropoulos M H, Higgins J J, Golbe L I et al.. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23.  Science. 1996;  274(5290) 1197-1199
• 4 Conner K E, Rosenberg R N. The genetic basis of ataxia. In: Rosenberg RN, Prusiner SV, Di Mauro S, Barcha RS The Molecular and Genetic Basis of Neurological Disease. Boston; Butterworth-Heinemann 1997: 503-544
• 5 Boeve B F, Silber M H, Parisi J E et al.. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism.  Neurology. 2003;  61(1) 40-45
• 6 Schenck C H, Mahowald M W. A polysomnographic, neurologic, psychiatric and clinical outcome report on 70 consecutive cases with REM sleep behavior disorder (RBD): Sustained clonazepam efficacy in 89.5% of 57 treated patients.  Cleve Clin J Med. 1990;  57(Suppl) 10-24
• 7 Katzman R, Terry R. The Neurology of Aging. Philadelphia; Davis 1983
• 8 McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.  Neurology. 1984;  34(7) 939-944
• 9 Vitiello M V, Prinz P N. Alzheimer's disease. Sleep and sleep/wake patterns.  Clin Geriatr Med. 1989;  5(2) 289-299
• 10 Moe K E, Vitiello M V, Larsen L H, Prinz P N. Symposium: cognitive processes and sleep disturbances: sleep/wake patterns in Alzheimer's disease: relationships with cognition and function.  J Sleep Res. 1995;  4(1) 15-20
• 11 Hoch C C, Reynolds III C F, Kupfer D J, Houck P R, Berman S R, Stack J A. Sleep-disordered breathing in normal and pathologic aging.  J Clin Psychiatry. 1986;  47(10) 499-503
• 12 Erkinjuntti T, Partinen M, Sulkava R, Telakivi T, Salmi T, Tilvis R. Sleep apnea in multiinfarct dementia and Alzheimer's disease.  Sleep. 1987;  10(5) 419-425
• 13 Loewenstein R J, Weingartner H, Gillin J C, Kaye W, Ebert M, Mendelson W B. Disturbances of sleep and cognitive functioning in patients with dementia.  Neurobiol Aging. 1982;  3(4) 371-377
• 14 Reynolds III C F, Kupfer D J, Houck P R et al.. Reliable discrimination of elderly depressed and demented patients by electroencephalographic sleep data.  Arch Gen Psychiatry. 1988;  45(3) 258-264
• 15 Allen S R, Seiler W O, Stähelin H B, Spiegel R. Seventy-two hour polygraphic and behavioral recordings of wakefulness and sleep in a hospital geriatric unit: comparison between demented and nondemented patients.  Sleep. 1987;  10(2) 143-159
• 16 Feinberg I, Koresko R L, Heller N. EEG sleep patterns as a function of normal and pathological aging in man.  J Psychiatr Res. 1967;  5(2) 107-144
• 17 Prinz P N, Peskind E R, Vitaliano P P et al.. Changes in the sleep and waking EEGs of nondemented and demented elderly subjects.  J Am Geriatr Soc. 1982;  30(2) 86-93
• 18 Montplaisir J, Petit D, Lorrain D, Gauthier S, Nielsen T. Sleep in Alzheimer's disease: further considerations on the role of brainstem and forebrain cholinergic populations in sleep-wake mechanisms.  Sleep. 1995;  18(3) 145-148
• 19 Benca R M, Obermeyer W H, Thisted R A, Gillin J C. Sleep and psychiatric disorders. A meta-analysis.  Arch Gen Psychiatry. 1992;  49(8) 651-668 discussion 669-670
• 20 Bliwise D L. Dementia. In: Kryger MH, Roth T, Dement WC Principles and Practice of Sleep Medicine. Philadelphia; Saunders 1994: 790
• 21 Vitiello M V, Prinz P N, Williams D E, Frommlet M S, Ries R K. Sleep disturbances in patients with mild-stage Alzheimer's disease.  J Gerontol. 1990;  45(4) M131-M138
• 22 Prinz P N, Peskind E R, Vitaliano P P et al.. Changes in the sleep and waking EEGs of nondemented and demented elderly subjects.  J Am Geriatr Soc. 1982;  30(2) 86-93
• 23 Bliwise D L, Tinklenberg J, Yesavage J A et al.. REM latency in Alzheimer's disease.  Biol Psychiatry. 1989;  25(3) 320-328
• 24 Yesavage J A, Taylor J L, Kraemer H, Noda A, Friedman L, Tinklenberg J R. Sleep/wake cycle disturbance in Alzheimer's disease: how much is due to an inherent trait?.  Int Psychogeriatr. 2002;  14(1) 73-81
• 25 Onen F, Onen S H. [Sleep rhythm disturbances in Alzheimer's disease].  Rev Med Interne. 2003;  24(3) 165-171
• 26 Crowley K, Sullivan E V, Adalsteinsson E, Pfefferbaum A, Colrain I M. Differentiating pathologic delta from healthy physiologic delta in patients with Alzheimer disease.  Sleep. 2005;  28(7) 865-870
• 27 Boddy F, Rowan E N, Lett D, O'Brien J T, McKeith I G, Burn D J. Subjectively reported sleep quality and excessive daytime somnolence in Parkinson's disease with and without dementia, dementia with Lewy bodies and Alzheimer's disease.  Int J Geriatr Psychiatry. 2007;  22(6) 529-535
• 28 Park M, Comella C L, Leurgans S E, Fan W, Wilson R S, Bennett D A. Association of daytime napping and Parkinsonian signs in Alzheimer's disease.  Sleep Med. 2006;  7(8) 614-618
• 29 Taylor J L, Friedman L, Sheikh J, Yesavage J A. Assessment and management of “Sundowning” phenomena.  Semin Clin Neuropsychiatry. 1997;  2(2) 113-122
• 30 Vitiello M V, Bliwise D L, Prinz P N. Sleep in Alzheimer's disease and the sundown syndrome.  Neurology. 1992;  42(7, Suppl 6) 83-93 discussion 93-94
• 31 Wu Y H, Swaab D F. Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer's disease.  Sleep Med. 2007;  8(6) 623-636
• 32 Wu Y H, Swaab D F. The human pineal gland and melatonin in aging and Alzheimer's disease.  J Pineal Res. 2005;  38(3) 145-152
• 33 Chokroverty S. Sleep, breathing, and neurologic disorders. In: Chokroverty S Sleep Disorders Medicine: Basic Science, Technical Considerations, and Clinical Aspects. 3rd ed. Philadelphia; Elsevier/Butterworth 2009
• 34 Bliwise D L. Sleep apnea, APOE4 and Alzheimer's disease 20 years and counting?.  J Psychosom Res. 2002;  53(1) 539-546
• 35 Grace J B, Walker M P, McKeith I G. A comparison of sleep profiles in patients with dementia with Lewy bodies and Alzheimer's disease.  Int J Geriatr Psychiatry. 2000;  15(11) 1028-1033
• 36 Bahro M, Riemann D, Stadtmüller G, Berger M, Gattaz W F. REM sleep parameters in the discrimination of probable Alzheimer's disease from old-age depression.  Biol Psychiatry. 1993;  34(7) 482-486
• 37 Dykierek P, Stadtmüller G, Schramm P et al.. The value of REM sleep parameters in differentiating Alzheimer's disease from old-age depression and normal aging.  J Psychiatr Res. 1998;  32(1) 1-9
• 38 Sinforiani E, Terzaghi M, Pasotti C, Zucchella C, Zambrelli E, Manni R. Hallucinations and sleep-wake cycle in Alzheimer's disease: a questionnaire-based study in 218 patients.  Neurol Sci. 2007;  28(2) 96-99
• 39 Gagnon J F, Petit D, Fantini M L et al.. REM sleep behavior disorder and REM sleep without atonia in probable Alzheimer disease.  Sleep. 2006;  29(10) 1321-1325
• 40 Bonanni E, Maestri M, Tognoni G et al.. Daytime sleepiness in mild and moderate Alzheimer's disease and its relationship with cognitive impairment.  J Sleep Res. 2005;  14(3) 311-317
• 41 Park M, Comella C L, Leurgans S E, Fan W, Wilson R S, Bennett D A. Association of daytime napping and Parkinsonian signs in Alzheimer's disease.  Sleep Med. 2006;  7(8) 614-618
• 42 Rajput A, Rajput A H. Progressive supranuclear palsy: clinical features, pathophysiology and management.  Drugs Aging. 2001;  18(12) 913-925
• 43 Aldrich M S, Foster N L, White R F, Bluemlein L, Prokopowicz G. Sleep abnormalities in progressive supranuclear palsy.  Ann Neurol. 1989;  25(6) 577-581
• 44 Chokroverty S. Sleep and degenerative neurologic disorders.  Neurol Clin. 1996;  14(4) 807-826
• 45 Perret J L, Jouvet M. [Sleep study of progressive supranuclear paralysis].  Electroencephalogr Clin Neurophysiol. 1980;  49(3-4) 323-329
• 46 De Bruin V S, Machado C, Howard R S, Hirsch N P, Lees A J. Nocturnal and respiratory disturbances in Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).  Postgrad Med J. 1996;  72(847) 293-296
• 47 Arnulf I, Merino-Andreu M, Bloch F et al.. REM sleep behavior disorder and REM sleep without atonia in patients with progressive supranuclear palsy.  Sleep. 2005;  28(3) 349-354
• 48 Sixel-Döring F, Schweitzer M, Mollenhauer B, Trenkwalder C. Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy.  Sleep Med. 2009;  10(4) 407-415
• 49 Pareja J A, Caminero A B, Masa J F, Dobato J L. A first case of progressive supranuclear palsy and pre-clinical REM sleep behavior disorder presenting as inhibition of speech during wakefulness and somniloquy with phasic muscle twitching during REM sleep.  Neurologia. 1996;  11(8) 304-306
• 50 Massetani R, Arena R, Bonuccelli U, Salerno P, Muratorio A. [Sleep in progressive supranuclear palsy].  Riv Patol Nerv Ment. 1982;  103(5) 215-224
• 51 Perret J L, Jouvet M. [Sleep study of progressive supranuclear paralysis].  Electroencephalogr Clin Neurophysiol. 1980;  49(3-4) 323-329
• 52 Laffont F, Leger J M, Penicaud A et al.. [Sleep abnormalities and evoked potentials (VEP-BAER-SEP) in progressive supranuclear palsy].  Neurophysiol Clin. 1988;  18(3) 255-269
• 53 Montplaisir J, Petit D, Décary A et al.. Sleep and quantitative EEG in patients with progressive supranuclear palsy.  Neurology. 1997;  49(4) 999-1003
• 54 Yasui K, Inoue Y, Kanbayashi T, Nomura T, Kusumi M, Nakashima K. CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration.  J Neurol Sci. 2006;  250(1-2) 120-123
• 55 Stover N P, Watts R L. Corticobasal degeneration.  Semin Neurol. 2001;  21(1) 49-58
• 56 Wenning G K, Litvan I, Jankovic J et al.. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination.  J Neurol Neurosurg Psychiatry. 1998;  64(2) 184-189
• 57 Dickson D W. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration.  J Neurol. 1999;  246(Suppl 2) II6-II15
• 58 Wetter T C, Brunner H, Collado-Seidel V, Trenkwalder C, Winkelmann J. Sleep and periodic limb movements in corticobasal degeneration.  Sleep Med. 2002;  3(1) 33-36
• 59 Iriarte J, Alegre M, Arbizu J, de Castro P. Unilateral periodic limb movements during sleep in corticobasal degeneration.  Mov Disord. 2001;  16(6) 1180-1183
• 60 Caselli R J, Boeve B F. The degenerative dementia. In: Goetz CG Textbook of Clinical Neurology. Philadelphia; Saunders/Elsevier 2007: 699-733
• 61 Liu W, Miller B L, Kramer J H et al.. Behavioral disorders in the frontal and temporal variants of frontotemporal dementia.  Neurology. 2004;  62(5) 742-748
• 62 Partinen M. Sleep disorder related to Parkinson's disease.  J Neurol. 1997;  244(4, Suppl 1) S3-S6
• 63 Kumar S, Bhatia M, Behari M. Sleep disorders in Parkinson's disease.  Mov Disord. 2002;  17(4) 775-781
• 64 Lees A J, Blackburn N A, Campbell V L. The nighttime problems of Parkinson's disease.  Clin Neuropharmacol. 1988;  11(6) 512-519
• 65 Factor S A, McAlarney T, Sanchez-Ramos J R, Weiner W J. Sleep disorders and sleep effect in Parkinson's disease.  Mov Disord. 1990;  5(4) 280-285
• 66 Trenkwalder C. Sleep dysfunction in Parkinson's disease.  Clin Neurosci. 1998;  5(2) 107-114
• 67 Karlsen K H, Larsen J P, Tandberg E, Maeland J G. Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease.  J Neurol Neurosurg Psychiatry. 1999;  66(4) 431-435
• 68 Schenck C H, Bundlie S R, Ettinger M G, Mahowald M W. Chronic behavioral disorders of human REM sleep: a new category of parasomnia.  Sleep. 1986;  9(2) 293-308
• 69 Schenck C H, Bundlie S R, Mahowald M W. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder.  Neurology. 1996;  46(2) 388-393
• 70 Frucht S, Rogers J D, Greene P E, Gordon M F, Fahn S. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole.  Neurology. 1999;  52(9) 1908-1910
• 71 Comella C L, Morrissey M, Janko K. Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy.  Neurology. 2005;  64(8) 1450-1451
• 72 Arnulf I. Sleep and wakefulness disturbances in Parkinson's disease.  J Neural Transm Suppl. 2006;  (70) 357-360
• 73 Stack E L, Ashburn A M. Impaired bed mobility and disordered sleep in Parkinson's disease.  Mov Disord. 2006;  21(9) 1340-1342
• 74 Borek L L, Kohn R, Friedman J H. Mood and sleep in Parkinson's disease.  J Clin Psychiatry. 2006;  67(6) 958-963
• 75 Verbaan D, van Rooden S M, Visser M, Marinus J, van Hilten J J. Nighttime sleep problems and daytime sleepiness in Parkinson's disease.  Mov Disord. 2007;  23(1) 35-41
• 76 Currie L J, Bennett Jr J P, Harrison M B, Trugman J M, Wooten G F. Clinical correlates of sleep benefit in Parkinson's disease.  Neurology. 1997;  48(4) 1115-1117
• 77 Merello M, Hughes A, Colosimo C, Hoffman M, Starkstein S, Leiguarda R. Sleep benefit in Parkinson's disease.  Mov Disord. 1997;  12(4) 506-508
• 78 Högl B E, Gómez-Arévalo G, García S et al.. A clinical, pharmacologic, and polysomnographic study of sleep benefit in Parkinson's disease.  Neurology. 1998;  50(5) 1332-1339
• 79 Poceta J S, Parsons L, Engelland S, Kripke D F. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease.  Sleep Med. 2009;  10(1) 129-133
• 80 Yamamura Y, Hattori N, Matsumine H, Kuzuhara S, Mizuno Y. Autosomal recessive early-onset parkinsonism with diurnal fluctuation: clinicopathologic characteristics and molecular genetic identification.  Brain Dev. 2000;  22(Suppl 1) S87-S91
• 81 Valente E M, Brancati F, Ferraris A European Consortium on Genetic Susceptibility in Parkinson's Disease et al. PARK6-linked parkinsonism occurs in several European families.  Ann Neurol. 2002;  51(1) 14-18
• 82 Scaglione C, Vignatelli L, Plazzi G Bologna, Genova, Parma and Pisa Universities group for the study of REM Sleep Behavior Disorder in Parkinson's Disease et al. REM sleep behaviour disorder in Parkinson's disease: a questionnaire-based study.  Neurol Sci. 2005;  25(6) 316-321
• 83 Rye D B. Contributions of the pedunculopontine region to normal and altered REM sleep.  Sleep. 1997;  20(9) 757-788
• 84 Rye D B. The two faces of Eve: dopamine's modulation of wakefulness and sleep.  Neurology. 2004;  63(8, Suppl 3) S2-S7
• 85 Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rub U. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages).  J Neurol. 2002;  249(Suppl 3) 1-5
• 86 Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K. Stages in the development of Parkinson's disease-related pathology.  Cell Tissue Res. 2004;  318(1) 121-134
• 87 Boeve B F, Silber M H, Saper C B et al.. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease.  Brain. 2007;  130(Pt 11) 2770-2788
• 88 Stiasny-Kolster K, Doerr Y, Möller J C et al.. Combination of ‘idiopathic’ REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.  Brain. 2005;  128(Pt 1) 126-137
• 89 Fantini M L, Postuma R B, Montplaisir J, Ferini-Strambi L. Olfactory deficit in idiopathic rapid eye movements sleep behavior disorder.  Brain Res Bull. 2006;  70(4-6) 386-390
• 90 Gagnon J F, Postuma R B, Mazza S, Doyon J, Montplaisir J. Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases.  Lancet Neurol. 2006;  5(5) 424-432
• 91 Postuma R B, Lang A E, Massicotte-Marquez J, Montplaisir J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder.  Neurology. 2006;  66(6) 845-851
• 92 Mazza S, Soucy J P, Gravel P et al.. Assessing whole brain perfusion changes in patients with REM sleep behavior disorder.  Neurology. 2006;  67(9) 1618-1622
• 93 Miyamoto T, Miyamoto M, Inoue Y, Usui Y, Suzuki K, Hirata K. Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder.  Neurology. 2006;  67(12) 2236-2238
• 94 Kumru H, Santamaria J, Tolosa E, Iranzo A. Relation between subtype of Parkinson's disease and REM sleep behavior disorder.  Sleep Med. 2007;  8(7-8) 779-783
• 95 Tuin I, Voss U, Kessler K et al.. Sleep quality in a family with hereditary parkinsonism (PARK6).  Sleep Med. 2008;  9(6) 684-688
• 96 Benbir G, Ozekmekçi S, Cinar M, Beskardes F, Apaydin H, Erginöz E. Features associated with the development of hallucinations in Parkinson's disease.  Acta Neurol Scand. 2006;  114(4) 239-243
• 97 Onofrj M, Bonanni L, Albani G, Mauro A, Bulla D, Thomas A. Visual hallucinations in Parkinson's disease: clues to separate origins.  J Neurol Sci. 2006;  248(1-2) 143-150
• 98 Vendette M, Gagnon J F, Décary A et al.. REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia.  Neurology. 2007;  69(19) 1843-1849
• 99 De Cock V C, Vidailhet M, Leu S et al.. Restoration of normal motor control in Parkinson's disease during REM sleep.  Brain. 2007;  130(Pt 2) 450-456
• 100 Braga-Neto P, da Silva-Júnior F P, Sueli Monte F, de Bruin P F, de Bruin V M. Snoring and excessive daytime sleepiness in Parkinson's disease.  J Neurol Sci. 2004;  217(1) 41-45
• 101 Tandberg E, Larsen J P, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study.  Mov Disord. 1999;  14(6) 922-927
• 102 Ondo W G, Dat Vuong K, Khan H, Atassi F, Kwak C, Jankovic J. Daytime sleepiness and other sleep disorders in Parkinson's disease.  Neurology. 2001;  57(8) 1392-1396
• 103 Pal S, Bhattacharya K F, Agapito C, Chaudhuri K R. A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy.  J Neural Transm. 2001;  108(1) 71-77
• 104 Tracik F, Ebersbach G. Sudden daytime sleep onset in Parkinson's disease: polysomnographic recordings.  Mov Disord. 2001;  16(3) 500-506
• 105 Arnulf I. Excessive daytime sleepiness in parkinsonism.  Sleep Med Rev. 2005;  9(3) 185-200
• 106 Meindorfner C, Körner Y, Möller J C, Stiasny-Kolster K, Oertel W H, Krüger H P. Driving in Parkinson's disease: mobility, accidents, and sudden onset of sleep at the wheel.  Mov Disord. 2005;  20(7) 832-842
• 107 Möller J C, Rethfeldt M, Körner Y et al.. Daytime sleep latency in medication-matched Parkinsonian patients with and without sudden onset of sleep.  Mov Disord. 2005;  20(12) 1620-1622
• 108 Rissling I, Körner Y, Geller F, Stiasny-Kolster K, Oertel W H, Möller J C. Preprohypocretin polymorphisms in Parkinson disease patients reporting “sleep attacks”.  Sleep. 2005;  28(7) 871-875
• 109 Rissling I, Geller F, Bandmann O et al.. Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting “sleep attacks”.  Mov Disord. 2004;  19(11) 1279-1284
• 110 Rye D B, Johnston L H, Watts R L, Bliwise D L. Juvenile Parkinson's disease with REM sleep behavior disorder, sleepiness, and daytime REM onset.  Neurology. 1999;  53(8) 1868-1870
• 111 Baumann C, Ferini-Strambi L, Waldvogel D, Werth E, Bassetti C L. Parkinsonism with excessive daytime sleepiness—a narcolepsy-like disorder?.  J Neurol. 2005;  252(2) 139-145
• 112 Thannickal T C, Lai Y Y, Siegel J M. Hypocretin (orexin) cell loss in Parkinson's disease.  Brain. 2007;  130(Pt 6) 1586-1595
• 113 Gjerstad M D, Wentzel-Larsen T, Aarsland D, Larsen J P. Insomnia in Parkinson's disease: frequency and progression over time.  J Neurol Neurosurg Psychiatry. 2007;  78(5) 476-479
• 114 Askenasy J J. Sleep in Parkinson's disease.  Acta Neurol Scand. 1993;  87(3) 167-170
• 115 Chokroverty S. Sleep in neurodegenerative diseases. In: Culebras A Sleep Disorders and Neurological Disease. New York; Marcel Dekker Inc 2000: 217
• 116 Hening W A, Allen R, Walters A S, Chokroverty S. Motor functions and dysfunctions of sleep. In: Chokroverty S Sleep Disorders Medicine: Basic Science, Technical Considerations and Clinical Aspects. Philadelphia; Saunders/Elsevier 2009: 397-435
• 117 Vas C J, Parsonage M, Lord O C. Parkinsonism associated with laryngeal spasm.  J Neurol Neurosurg Psychiatry. 1965;  28(5) 401-403
• 118 Corbin D O, Williams A C. Stridor during dystonic phases of Parkinson's disease.  J Neurol Neurosurg Psychiatry. 1987;  50(6) 821-822
• 119 Vincken W G, Gauthier S G, Dollfuss R E, Hanson R E, Darauay C M, Cosio M G. Involvement of upper-airway muscles in extrapyramidal disorders. A cause of airflow limitation.  N Engl J Med. 1984;  311(7) 438-442
• 120 Efthimiou J, Ellis S J, Hardie R J, Stern G M. Sleep apnea in idiopathic and postencephalitic parkinsonism. In: Yahr MD, Bergmann KJ Parkinson's Disease (Advances in Neurology 45). New York; Raven Press 1986: 275-276
• 121 Ondo W G, Vuong K D, Jankovic J. Exploring the relationship between Parkinson disease and restless legs syndrome.  Arch Neurol. 2002;  59(3) 421-424
• 122 Garcia-Borreguero D, Odin P, Serrano C. Restless legs syndrome and PD: a review of the evidence for a possible association.  Neurology. 2003;  61(6, Suppl 3) S49-S55
• 123 Krishnan P R, Bhatia M, Behari M. Restless legs syndrome in Parkinson's disease: a case-controlled study.  Mov Disord. 2003;  18(2) 181-185
• 124 Adel S, Djarmati A, Kabakci K et al.. Co-occurrence of restless legs syndrome and Parkin mutations in two families.  Mov Disord. 2006;  21(2) 258-263
• 125 Poewe W, Högl B. Akathisia, restless legs and periodic limb movements in sleep in Parkinson's disease.  Neurology. 2004;  63(8, Suppl 3) S12-S16
• 126 Allen R P, Earley C J. Augmentation of the restless legs syndrome with carbidopa/levodopa.  Sleep. 1996;  19(3) 205-213
• 127 Kedia S, Moro E, Tagliati M, Lang A E, Kumar R. Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease.  Neurology. 2004;  63(12) 2410-2412
• 128 Wetter T C, Collado-Seidel V, Pollmächer T, Yassouridis A, Trenkwalder C. Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy.  Sleep. 2000;  23(3) 361-367
• 129 Happe S, Pirker W, Klösch G, Sauter C, Zeitlhofer J. Periodic leg movements in patients with Parkinson's disease are associated with reduced striatal dopamine transporter binding.  J Neurol. 2003;  250(1) 83-86
• 130 Wetter T C, Brunner H, Högl B, Yassouridis A, Trenkwalder C, Friess E. Increased alpha activity in REM sleep in de novo patients with Parkinson's disease.  Mov Disord. 2001;  16(5) 928-933
• 131 Happe S, Schrödl B, Faltl M, Müller C, Auff E, Zeitlhofer J. Sleep disorders and depression in patients with Parkinson's disease.  Acta Neurol Scand. 2001;  104(5) 275-280
• 132 Purdy A, Hahn A, Barnett H J et al.. Familial fatal Parkinsonism with alveolar hypoventilation and mental depression.  Ann Neurol. 1979;  6(6) 523-531
• 133 Mouret J. Differences in sleep in patients with Parkinson's disease.  Electroencephalogr Clin Neurophysiol. 1975;  38(6) 653-657
• 134 Weisman D, McKeith I. Dementia with Lewy bodies.  Semin Neurol. 2007;  27(1) 42-47
• 135 McKeith I G, Dickson D W, Lowe J Consortium on DLB et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.  Neurology. 2005;  65(12) 1863-1872
• 136 Ferman T J, Boeve B F, Smith G E et al.. Dementia with Lewy bodies may present as dementia and REM sleep behavior disorder without parkinsonism or hallucinations.  J Int Neuropsychol Soc. 2002;  8(7) 907-914
• 137 Boeve B F, Silber M H, Ferman T J. REM sleep behavior disorder in Parkinson's disease and dementia with Lewy bodies.  J Geriatr Psychiatry Neurol. 2004;  17(3) 146-157
• 138 Boeve B F, Silber M H, Ferman T J et al.. REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease.  Neurology. 1998;  51(2) 363-370
• 139 Boeve B F, Silber M H, Ferman T J, Lucas J A, Parisi J E. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy.  Mov Disord. 2001;  16(4) 622-630
• 140 Olson E J, Boeve B F, Silber M H. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases.  Brain. 2000;  123(Pt 2) 331-339
• 141 Boeve B F, Dickson D W, Olson E J et al.. Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease.  Sleep Med. 2007;  8(1) 60-64
• 142 Uchiyama M, Isse K, Tanaka K et al.. Incidental Lewy body disease in a patient with REM sleep behavior disorder.  Neurology. 1995;  45(4) 709-712
• 143 Harper D G, Stopa E G, McKee A C, Satlin A, Fish D, Volicer L. Dementia severity and Lewy bodies affect circadian rhythms in Alzheimer disease.  Neurobiol Aging. 2004;  25(6) 771-781
• 144 Baumann C R, Dauvilliers Y, Mignot E, Bassetti C L. Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated with excessive daytime sleepiness.  Eur Neurol. 2004;  52(2) 73-76
• 145 Gilman S, Low P, Quinn N et al.. [Consensus on the diagnosis of multi-system atrophy].  Neurologia. 1999;  14(9) 425-428
• 146 Gilman S, Wenning G K, Low P A et al.. Second consensus statement on the diagnosis of multiple system atrophy.  Neurology. 2008;  71(9) 670-676
• 147 Plazzi G, Corsini R, Provini F et al.. REM sleep behavior disorders in multiple system atrophy.  Neurology. 1997;  48(4) 1094-1097
• 148 Iranzo A, Molinuevo J L, Santamaría J et al.. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study.  Lancet Neurol. 2006;  5(7) 572-577
• 149 Iranzo A, Santamaría J, Rye D B et al.. Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD.  Neurology. 2005;  65(2) 247-252
• 150 Gilman S, Koeppe R A, Chervin R D et al.. REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA.  Neurology. 2003;  61(1) 29-34
• 151 Benarroch E E. Brainstem in multiple system atrophy: clinicopathological correlations.  Cell Mol Neurobiol. 2003;  23(4-5) 519-526
• 152 Plazzi G, Corsini R, Provini F et al.. REM sleep behavior disorders in multiple system atrophy.  Neurology. 1997;  48(4) 1094-1097
• 153 Bannister R, Gibson W, Michaels L, Oppenheimer D R. Laryngeal abductor paralysis in multiple system atrophy. A report on three necropsied cases, with observations on the laryngeal muscles and the nuclei ambigui.  Brain. 1981;  104(2) 351-368
• 154 Cunchillos J D, De Andrés I. Participation of the cerebellum in the regulation of the sleep-wakefulness cycle. Results in cerebellectomized cats.  Electroencephalogr Clin Neurophysiol. 1982;  53(5) 549-558
• 155 Kitamura J, Kubuki Y, Tsuruta K, Kurihara T, Matsukura S. A new family with Joseph disease in Japan. Homovanillic acid, magnetic resonance, and sleep apnea studies.  Arch Neurol. 1989;  46(4) 425-428
• 156 Chokroverty S, Sachdeo R, Masdeu J. Autonomic dysfunction and sleep apnea in olivopontocerebellar degeneration.  Arch Neurol. 1984;  41(9) 926-931
• 157 Salazar-Grueso E F, Rosenberg R S, Roos R P. Sleep apnea in olivopontocerebellar degeneration: treatment with trazodone.  Ann Neurol. 1988;  23(4) 399-401
• 158 Salva M A, Guilleminault C. Olivopontocerebellar degeneration, abnormal sleep, and REM sleep without atonia.  Neurology. 1986;  36(4) 576-577
• 159 Abele M, Bürk K, Laccone F, Dichgans J, Klockgether T. Restless legs syndrome in spinocerebellar ataxia types 1, 2, and 3.  J Neurol. 2001;  248(4) 311-314
• 160 Friedman J H. Presumed rapid eye movement behavior disorder in Machado-Joseph disease (spinocerebellar ataxia type 3).  Mov Disord. 2002;  17(6) 1350-1353
• 161 Iranzo A, Muñoz E, Santamaria J, Vilaseca I, Milà M, Tolosa E. REM sleep behavior disorder and vocal cord paralysis in Machado-Joseph disease.  Mov Disord. 2003;  18(10) 1179-1183
• 162 Boesch S M, Frauscher B, Brandauer E, Wenning G K, Högl B, Poewe W. Disturbance of rapid eye movement sleep in spinocerebellar ataxia type 2.  Mov Disord. 2006;  21(10) 1751-1754
• 163 Tuin I, Voss U, Kang J S et al.. Stages of sleep pathology in spinocerebellar ataxia type 2 (SCA2).  Neurology. 2006;  67(11) 1966-1972
• 164 Boesch S M, Frauscher B, Brandauer E, Wenning G K, Poewe W, Högl B. Restless legs syndrome and motor activity during sleep in spinocerebellar ataxia type 6.  Sleep Med. 2006;  7(6) 529-532
• 165 Howell M J, Mahowald M W, Gomez C M. Evaluation of sleep and daytime somnolence in spinocerebellar ataxia type 6 (SCA6).  Neurology. 2006;  66(9) 1430-1431
• 166 Tassinari C A, Broughton R, Poire R et al.. Sur l'Evolution des Mouvements Anormaux au Cours du Sommeil. In: Fischgold H Le Sommeil de Nuit Normal et Pathologique. Paris; Masson 1965: 314
• 167 Askenasy J JM. Sleep patterns in extrapyramidal disorders.  Int J Neurol. 1981;  15(1-2) 62-76
• 168 Spire J P, Bliwise D L, Noronha A BC, Roos R P. Sleep profiles in Huntington disease.  Neurology. 1981;  31(2) 151
• 169 Fish D R, Sawyers D, Allen P J, Blackie J D, Lees A J, Marsden C D. The effect of sleep on the dyskinetic movements of Parkinson's disease, Gilles de la Tourette syndrome, Huntington's disease, and torsion dystonia.  Arch Neurol. 1991;  48(2) 210-214
• 170 Iakhno N N. [Disorders of nocturnal sleep in Huntington chorea].  Zh Nevropatol Psikhiatr Im S S Korsakova. 1985;  85(3) 340-346
• 171 Emser W, Brenner M, Stober T, Schimrigk K. Changes in nocturnal sleep in Huntington's and Parkinson's disease.  J Neurol. 1988;  235(3) 177-179
• 172 Sishta S K, Troupe A, Marszalek K S, Kremer L M. Huntington's chorea: an electroencephalographic and psychometric study.  Electroencephalogr Clin Neurophysiol. 1974;  36(4) 387-393
• 173 Puca F M, Genco S, Minervini M G et al.. [Sleep in chronic chorea patients after therapy with sodium valproate].  Boll Soc Ital Biol Sper. 1984;  60(5) 989-992
• 174 Wiegand M, Möller A A, Lauer C J et al.. Nocturnal sleep in Huntington's disease.  J Neurol. 1991;  238(4) 203-208
• 175 Hurelbrink C B, Lewis S J, Barker R A. The use of the Actiwatch-Neurologica system to objectively assess the involuntary movements and sleep-wake activity in patients with mild-moderate Huntington's disease.  J Neurol. 2005;  252(6) 642-647
• 176 Morton A J, Wood N I, Hastings M H, Hurelbrink C, Barker R A, Maywood E S. Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease.  J Neurosci. 2005;  25(1) 157-163
• 177 Yamamoto T, Hirose G, Shimazaki K, Takado S, Kosoegawa H, Saeki M. Movement disorders of familial neuroacanthocytosis syndrome.  Arch Neurol. 1982;  39(5) 298-301
• 178 Danek A, Jung H H, Metone M A et al.. Neuroacanthocytosis: new developments in a neglected group of dementing disorders.  J Neurol Sci. 2005;  229–230 171-186
• 179 Silvestri R, De Domenico P, Di Rosa A E, Bramanti P, Serra S, Di Perri R. The effect of nocturnal physiological sleep on various movement disorders.  Mov Disord. 1990;  5(1) 8-14
• 180 Silvestri R, Raffaele M, De Domenico P et al.. Sleep features in Tourette's syndrome, neuroacanthocytosis and Huntington's chorea.  Neurophysiol Clin. 1995;  25(2) 66-77
• 181 Hernández Vara J, Fernández Cortijo J, Purroy García F, Miquel Rodríguez F. [Restless legs syndrome and neuroacanthocytosis].  Med Clin (Barc). 2005;  124(18) 717-718
• 182 Jankel W R, Niedermeyer E, Graf M, Kalsher M J, Kalsher M J. Case report: polysomnographic effects of thalamotomy for torsion dystonia.  Neurosurgery. 1984;  14(4) 495-498
• 183 Jankel W R, Allen R P, Niedermeyer E, Kalsher M J. Polysomnographic findings in dystonia musculorum deformans.  Sleep. 1983;  6(3) 281-285
• 184 Jankel W R, Niedermeyer E, Graf M, Kalsher M J. Polysomnography of torsion dystonia.  Arch Neurol. 1984;  41(10) 1081-1083
• 185 Wein A, Golubev V. Polygraphic analysis of sleep in dystonia musculorum deformans.  Waking Sleeping. 1979;  3(1) 41-50
• 186 Segawa M, Hosaka A, Miyagawa F, Nomura Y, Imai H. Hereditary progressive dystonia with marked diurnal fluctuation.  Adv Neurol. 1976;  14 215-233
• 187 Segawa M. Hereditary progressive dystonia with marked diurnal fluctuation.  Brain Dev. 2000;  22(Suppl 1) S65-S80
• 188 Ichinose H, Ohye T, Takahashi E et al.. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene.  Nat Genet. 1994;  8(3) 236-242
• 189 Ichinose H, Ohye T, Matsuda Y et al.. Characterization of mouse and human GTP cyclohydrolase I genes. Mutations in patients with GTP cyclohydrolase I deficiency.  J Biol Chem. 1995;  270(17) 10062-10071
• 190 Sawle G V, Leenders K L, Brooks D J et al.. Dopa-responsive dystonia: [18F]dopa positron emission tomography.  Ann Neurol. 1991;  30(1) 24-30
• 191 de Yebenes J G, Moskowitz C, Fahn S, Saint-Hilaire M H. Long-term treatment with levodopa in a family with autosomal dominant torsion dystonia. In: Fahn S, Marsden CD, Calne DB Dystonia 2. New York; Raven Press 1988: 101
• 192 Atalaia A, De Carvalho M, Evangelista T, Pinto A. Sleep characteristics of amyotrophic lateral sclerosis in patients with preserved diaphragmatic function.  Amyotroph Lateral Scler. 2007;  8(2) 101-105
• 193 Chokroverty S. Sleep, breathing and neuromuscular disorders. In: Montagna P, Chokroverty S Handbook of Clinical Neurology: Sleep Disorders. Amsterdam; Elsevier 2009
• 194 Kimura K, Tachibana N, Kimura J, Shibasaki H. Sleep-disordered breathing at an early stage of amyotrophic lateral sclerosis.  J Neurol Sci. 1999;  164(1) 37-43
• 195 Barthlen G M, Lange D J. Unexpectedly severe sleep and respiratory pathology in patients with amyotrophic lateral sclerosis.  Eur J Neurol. 2000;  7(3) 299-302
• 196 Takekawa H, Kubo J, Miyamoto T, Miyamoto M, Hirata K. Amyotrophic lateral sclerosis associated with insomnia and the aggravation of sleep-disordered breathing.  Psychiatry Clin Neurosci. 2001;  55(3) 263-264
• 197 Zweig R M, Jankel W R, Hedreen J C, Mayeux R, Price D L. The pedunculopontine nucleus in Parkinson's disease.  Ann Neurol. 1989;  26(1) 41-46
• 198 Jellinger K A. Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway.  Mol Chem Neuropathol. 1991;  14(3) 153-197
• 199 Paulus W, Jellinger K. The neuropathologic basis of different clinical subgroups of Parkinson's disease.  J Neuropathol Exp Neurol. 1991;  50(6) 743-755
• 200 Wenning G K, Tison F, Ben Shlomo Y, Daniel S E, Quinn N P. Multiple system atrophy: a review of 203 pathologically proven cases.  Mov Disord. 1997;  12(2) 133-147
• 201 Papp M I, Lantos P L. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology.  Brain. 1994;  117(Pt 2) 235-243
• 202 Gilman S, Chervin R D, Koeppe R A et al.. Obstructive sleep apnea is related to a thalamic cholinergic deficit in MSA.  Neurology. 2003;  61(1) 35-39
• 203 Hornykiewicz O, Kish S J, Becker L E, Farley I, Shannak K. Brain neurotransmitters in dystonia musculorum deformans.  N Engl J Med. 1986;  315(6) 347-353
• 204 Craig D, Hart D J, Passmore A P. Genetically increased risk of sleep disruption in Alzheimer's disease.  Sleep. 2006;  29(8) 1003-1007
• 205 Benarroch E E, Smithson I L, Low P A, Parisi J E. Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure.  Ann Neurol. 1998;  43(2) 156-163
• 206 Benarroch E E, Schmeichel A M, Parisi J E. Depletion of cholinergic neurons of the medullary arcuate nucleus in multiple system atrophy.  Auton Neurosci. 2001;  87(2-3) 293-299
• 207 Benarroch E E, Schmeichel A M. Depletion of corticotrophin-releasing factor neurons in the pontine micturition area in multiple system atrophy.  Ann Neurol. 2001;  50(5) 640-645
• 208 Benarroch E E, Schmeichel A M, Parisi J E. Depletion of mesopontine cholinergic and sparing of raphe neurons in multiple system atrophy.  Neurology. 2002;  59(6) 944-946
• 209 Benarroch E E, Schmeichel A M, Low P A, Parisi J E. Depletion of ventromedullary NK-1 receptor-immunoreactive neurons in multiple system atrophy.  Brain. 2003;  126(Pt 10) 2183-2190
• 210 Benarroch E E, Schmeichel A M, Low P A, Parisi J E. Depletion of putative chemosensitive respiratory neurons in the ventral medullary surface in multiple system atrophy.  Brain. 2007;  130(Pt 2) 469-475
• 211 Benarroch E E, Schmeichel A M, Low P A, Parisi J E. Involvement of medullary serotonergic groups in multiple system atrophy.  Ann Neurol. 2004;  55(3) 418-422
• 212 Benarroch E E, Schmeichel A M, Sandroni P, Low P A, Parisi J E. Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease.  Neurology. 2006;  66(3) 378-383
• 213 Benarroch E E, Schmeichel A M, Sandroni P, Low P A, Parisi J E. Involvement of hypocretin neurons in multiple system atrophy.  Acta Neuropathol. 2007;  113(1) 75-80
• 214 Benarroch E E. Brainstem respiratory chemosensitivity: new insights and clinical implications.  Neurology. 2007;  68(24) 2140-2143
• 215 Buée L, Bussière T, Buée-Scherrer V, Delacourte A, Hof P R. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders.  Brain Res Brain Res Rev. 2000;  33(1) 95-130
• 216 Forman M S, Lee V M, Trojanowski J Q. New insights into genetic and molecular mechanisms of brain degeneration in tauopathies.  J Chem Neuroanat. 2000;  20(3-4) 225-244
• 217 Duyckaerts C, Verny M, Hauw J J. [Recent neuropathology of parkinsonian syndromes].  Rev Neurol (Paris). 2003;  159(5 Pt 2) S11-S18
• 218 Krüger R, Müller T, Riess O. Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders.  J Neural Transm. 2000;  107(1) 31-40
• 219 Chung K K, Dawson V L, Dawson T M. New insights into Parkinson's disease.  J Neurol. 2003;  250(Suppl 3) III15-III24
• 220 Doherty M J, Bird T D, Leverenz J B. Alpha-synuclein in motor neuron disease: an immunohistologic study.  Acta Neuropathol. 2004;  107(2) 169-175
• 221 Chokroverty S. Polysomnography in movement disorders. In: Hallett M Handbook of Clinical Neurophysiology: Movement Disorders. Amsterdam; Elsevier 2003: 139
• 222 Tracik F, Ebersbach G. Sudden daytime sleep onset in Parkinson's disease: polysomnographic recordings.  Mov Disord. 2001;  16(3) 500-506
• 223 Hansotia P, Wall R, Berendes J. Sleep disturbances and severity of Huntington's disease.  Neurology. 1985;  35(11) 1672-1674
• 224 Diederich N J. Welcome to the club: Substantial sleep dysfunction also in Progressive Supranuclear Palsy.  Sleep Med. 2009;  10(4) 401-402
• 225 Fish D R, Allen P J, Sawyers D, Marsden C D. Sleep spindles in torsion dystonia.  Arch Neurol. 1990;  47(2) 216-218
• 226 Neil J F, Holzer B C, Spiker D G, Coble P A, Kupfer D J. EEG sleep alterations in olivopontocerebellar degeneration.  Neurology. 1980;  30(6) 660-662
• 227 McCurry S M, Reynolds C F, Ancoli-Israel S, Teri L, Vitiello M V. Treatment of sleep disturbance in Alzheimer's disease.  Sleep Med Rev. 2000;  4(6) 603-628
• 228 NCSDR Working Group . Insomnia: assessment and management in primary care.  Sleep. 1999;  22(Suppl 2) S402-S408
• 229 Drugs and insomnia: the use of medications to promote sleep.  Bol Asoc Med P R. 1986;  78(7) 306-310
• 230 National Institutes of Health Consensus Group . National Institutes of Health Consensus Development Conference Statement: the treatment of sleep disorders of older people March 26-28, 1990.  Sleep. 1991;  14(2) 169-177
• 231 McCurry S M, Ancoli-Israel S. Sleep dysfunction in Alzheimer's disease and other dementias.  Curr Treat Options Neurol. 2003;  5(3) 261-272
• 232 Zhdanova I V, Wurtman R J, Regan M M, Taylor J A, Shi J P, Leclair O U. Melatonin treatment for age-related insomnia.  J Clin Endocrinol Metab. 2001;  86(10) 4727-4730
• 233 Olde Rikkert M G, Rigaud A S. Melatonin in elderly patients with insomnia. A systematic review.  Z Gerontol Geriatr. 2001;  34(6) 491-497
• 234 Singer C, Tractenberg R, Kaye J et al.. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.  Sleep. 2003;  26 893-901
• 235 Bourke S C, Tomlinson M, Williams T L, Bullock R E, Shaw P J, Gibson G J. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial.  Lancet Neurol. 2006;  5(2) 140-147
• 236 Zesiewicz T A, Cimino C R, Malek A R et al.. Driving safety in Parkinson's disease.  Neurology. 2002;  59(11, 11) 1787-1788
• 237 Boeve B F, Silber M H, Ferman T J. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients.  Sleep Med. 2003;  4(4) 281-284
• 238 Takeuchi N, Uchimura N, Hashizume Y et al.. Melatonin therapy for REM sleep behavior disorder.  Psychiatry Clin Neurosci. 2001;  55(3) 267-269
• 239 Fantini M L, Gagnon J F, Filipini D, Montplaisir J. The effects of pramipexole in REM sleep behavior disorder.  Neurology. 2003;  61(10) 1418-1420
• 240 Ancoli-Israel S, Kripke D F, Klauber M R, Mason W J, Fell R, Kaplan O. Periodic limb movements in sleep in community-dwelling elderly.  Sleep. 1991;  14(6) 496-500
• 241 Campbell S S, Kripke D F, Gillin J C, Hrubovcak J C. Exposure to light in healthy elderly subjects and Alzheimer's patients.  Physiol Behav. 1988;  42(2) 141-144
• 242 Sumaya I C, Rienzi B M, Deegan II J F, Moss D E. Bright light treatment decreases depression in institutionalized older adults: a placebo-controlled crossover study.  J Gerontol A Biol Sci Med Sci. 2001;  56(6) M356-M360
• 243 Fetveit A, Bjorvatn B. Bright-light treatment reduces actigraphic-measured daytime sleep in nursing home patients with dementia: a pilot study.  Am J Geriatr Psychiatry. 2005;  13(5) 420-423
• 244 Ancoli-Israel S, Gehrman P, Martin J L et al.. Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer's disease patients.  Behav Sleep Med. 2003;  1(1) 22-36
• 245 Skjerve A, Holsten F, Aarsland D, Bjorvatn B, Nygaard H A, Johansen I M. Improvement in behavioral symptoms and advance of activity acrophase after short-term bright light treatment in severe dementia.  Psychiatry Clin Neurosci. 2004;  58(4) 343-347
• 246 Wu Y H, Swaab D F. Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer's disease.  Sleep Med. 2007;  8(6) 623-636
• 247 Dowling G A, Burr R L, Van Someren E J et al.. Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease.  J Am Geriatr Soc. 2008;  56(2) 239-246